PACS Form 144: Insider Sells 299,000 Shares

PACS reported insider sales by Mark Hancock via a Form 144 filing: 153,254 shares sold on 06/15/2026, 83,066 shares sold on 06/16/2026, and 63,680 shares sold on 06/17/2026.

Rhea-AI Filing Summary

PACS reported insider sales by Mark Hancock via a Form 144 filing: 153,254 shares sold on 06/15/2026, 83,066 shares sold on 06/16/2026, and 63,680 shares sold on 06/17/2026. The transactions are listed as Common stock dispositions with cash consideration.

Insights

Securities Counsel

Form 144 records reported sales by an affiliated holder over three days.

The filing lists three separate Common stock dispositions by Mark Hancock on 06/15/2026, 06/16/2026, and 06/17/2026, with specific share counts provided. The entries identify the transactions as sales for cash.

These entries are procedural disclosures required for restricted or control stock sales; further detail on whether sales were pursuant to a Rule 10b5-1 plan or other arrangement is not included in the provided excerpt.

Equity Capital Markets Analyst

Three-day insider selling pattern is visible; magnitude is explicit per date.

The filing lists 153,254, 83,066, and 63,680 shares sold on consecutive dates in mid-June 2026. Each row ties a sale to a cash consideration amount shown in the excerpt.

Cash‑flow treatment and post‑transaction holdings are not shown in the excerpt; subsequent filings would provide position context.

Key Figures

Sale on 06/15/2026: 153,254 shares Sale on 06/16/2026: 83,066 shares Sale on 06/17/2026: 63,680 shares +2 more

5 metrics

Sale on 06/15/2026 153,254 shares Common stock sold by Mark Hancock

Sale on 06/16/2026 83,066 shares Common stock sold by Mark Hancock

Sale on 06/17/2026 63,680 shares Common stock sold by Mark Hancock

Securities acquired at formation 54,626,199 shares listed under 'shares acquired at formation of the issuer' dated 03/01/2023

Listed exchange NYSE exchange indicated in the securities information line

Key Terms

Form 144, shares acquired at formation, issuer

3 terms

Form 144 regulatory

"144: Securities Sold During The Past 3 Months"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

shares acquired at formation other

"03/01/2023 | shares acquired at formation of the issuer"

issuer financial

"shares acquired at formation of the issuer | issuer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did PACS disclose in this Form 144?

Mark Hancock reported sales of Common stock on three dates. The filing lists sales of 153,254 shares on 06/15/2026, 83,066 shares on 06/16/2026, and 63,680 shares on 06/17/2026, each recorded as cash dispositions.

Who is the reporting person in the PACS Form 144 filing?

The filing identifies Mark Hancock as the reporting person. The document shows his address as 262 N. University Avenue, Farmington, UT 84025 alongside the three Common stock sale entries dated in June 2026.

Does the Form 144 excerpt state proceeds or dollar amounts for each sale?

The excerpt shows cash consideration amounts alongside each sale row. Each sale line includes a numeric cash figure in the provided excerpt, but the summary here lists the share counts and dates as the primary disclosed items.

Are the sold shares common stock and how were they described?

The securities are described as Common stock. The excerpt labels each transaction as Common stock dispositions and indicates the transactions were for cash.

Do we know if these sales were made under a trading plan (e.g., Rule 10b5-1)?

The provided excerpt does not state whether a trading plan was used. The filing lists sale dates and share counts but does not include footnotes or text identifying a prearranged trading plan in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/25/2026 - 06:27 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002014361
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PACS Group, Inc.
SEC File Number	001-42011
Address of Issuer	90 S. 400 W. SUITE 700 SALT LAKE CITY UTAH 84101
Phone	(801) 447-9829
Name of Person for Whose Account the Securities are To Be Sold	Hancock Mark
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director
Relationship to Issuer	10% Stockholder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Citigroup Global Markets Inc 388 Greenwich Street New York NY 10013	138069	5567701.46	15827237	06/25/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/01/2023	shares acquired at formation of the issuer	issuer			54626199	03/01/2023	cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Mark Hancock 262 N. University Avenue Farmington UT 84025	Common	06/15/2026	153254	5568759.95
Mark Hancock 262 N. University Avenue Farmington UT 84025	Common	06/16/2026	83066	2982385.05
Mark Hancock 262 N. University Avenue Farmington UT 84025	Common	06/17/2026	63680	2248413.44

144: Remarks and Signature

Remarks
Date of Notice	06/25/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/03/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Mark Darrell Hancock
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)